These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3621203)

  • 1. Immortalization of human lymphocytes from a tumor-involved lymph node.
    Glassy MC
    Cancer Res; 1987 Oct; 47(19):5181-8. PubMed ID: 3621203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
    Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
    Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal antibodies to nuclear antigens.
    McKnight ME; Koda K; DeBoer K; Glassy MC
    Hum Antibodies Hybridomas; 1990; 1(2):77-82. PubMed ID: 2103355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients.
    Kjeldsen TB; Rasmussen BB; Rose C; Zeuthen J
    Cancer Res; 1988 Jun; 48(11):3208-14. PubMed ID: 3365703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-human hybridomas generated with lymphocytes from patients with colorectal cancer.
    Borup-Christensen P; Erb K; Jensenius JC; Svehag SE; Nielsen B
    Cancer Detect Prev Suppl; 1987; 1():207-15. PubMed ID: 3480051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human monoclonal antibody directed to blood group i antigen: heterohybridoma between human lymphocytes from regional lymph nodes of a lung cancer patient and mouse myeloma.
    Hirohashi S; Clausen H; Nudelman E; Inoue H; Shimosato Y; Hakomori S
    J Immunol; 1986 Jun; 136(11):4163-8. PubMed ID: 2422274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
    Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
    Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in the secretion of monoclonal antibodies by human-human hybridomas.
    Gaffar SA; Surh CD; Glassy MC
    Hybridoma; 1986; 5(2):93-105. PubMed ID: 3721525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
    Strike LE; Devens BH; Lundak RL
    J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human X human hybridoma producing monoclonal antibody against autologous cervical carcinoma.
    Hagiwara H; Sato GH
    Mol Biol Med; 1983 Sep; 1(2):245-52. PubMed ID: 6334217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human monoclonal antibodies with human-mouse hybridomas].
    Naoe T; Kato K; Shiku H; Yamada K
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attempts to produce human monoclonal antibodies to melanoma using the cervical lymph nodes].
    Wilmes E; Funke I; Riethmüller G
    Laryngol Rhinol Otol (Stuttg); 1987 Mar; 66(3):144-8. PubMed ID: 3586798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the optimal human cell lines for development of human hybridomas.
    Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
    J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
    Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
    Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.